By Jacqueline Howard, CNN (CNN) — An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial. The regimen, which involves the immunotherapy drug nivolumab along with three different chemotherapies, was found to result in a two-year progression-free survival rate of 92% in a phase three trial whose results were published Wednesday in the New England Journal of Medicine. “At two years, 92% of the patients did not relapse, did not have progression of Hodgkin lymphoma and did not die,” Dr. Jonathan Friedberg, lead study author and director of the Wilmot Cancer Ins
Hence then, the article about immunotherapy improves survival in people with advanced hodgkin lymphoma study shows was published today ( ) and is available onNews channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Immunotherapy improves survival in people with advanced Hodgkin lymphoma, study shows )